These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11994678)

  • 21. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma insulin-like growth factor-I (IGF-I) and IGF-binding proteins.
    Nguyen-Yamamoto L; Deal CL; Finkelstein JA; Van Vliet G
    Endocrinology; 1994 Mar; 134(3):1382-8. PubMed ID: 7509740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
    Rasmussen MH; Juul A; Hilsted J
    Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroendocrine disturbances in obesity].
    Isidro ML; Alvarez P; Martínez T; Cordido F
    Rev Med Univ Navarra; 2004; 48(2):24-9. PubMed ID: 15382610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors.
    Maccario M; Grottoli S; Procopio M; Oleandri SE; Rossetto R; Gauna C; Arvat E; Ghigo E
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S96-9. PubMed ID: 10997620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth.
    Al-Samerria S; Radovick S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
    Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
    Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily patterns and adaptation of the ghrelin, growth hormone and insulin-like growth factor-1 system under daytime food synchronisation in rats.
    Arellanes-Licea Edel C; Báez-Ruiz A; Carranza ME; Arámburo C; Luna M; Díaz-Muñoz M
    J Neuroendocrinol; 2014 May; 26(5):282-95. PubMed ID: 24617825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.
    Luque RM; Kineman RD
    Endocrinology; 2006 Jun; 147(6):2754-63. PubMed ID: 16513828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
    Yamashita S; Melmed S
    Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J; Unterman TG; Frohman LA; Kineman RD
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catch-Up Growth: Basic Mechanisms.
    Griffin IJ
    Nestle Nutr Inst Workshop Ser; 2015; 81():87-97. PubMed ID: 26111566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.